Avalon GloboCare Corporation (ALBT): יחס מחיר להכנסות

Avalon GloboCare is developing a biomedical service, increasing profitability through the digitalization of diagnostics. Tracking the P/S time series on GURU.Markets, we note a pivot driven by the implementation of rapid tests and a unique protein modification technology against cancer. The value 3.90 represents the current level of the metric, confirming market expectations for the innovative pipeline and the company's strong pricing power.
פילוחים אנליטיים של חברת Avalon GloboCare Corp. (ALBT)

The P/S ratio determines the market value of a business relative to its annual sales volume. Current P/S dynamics reflect the ratio of total market capitalization to revenue, allowing for an assessment of the premium investors are paying per unit of income. This metric is highly sensitive to changes in operating flows and market expectations. For Avalon GloboCare (ALBT), such fluctuations are amplified by geopolitical risks that disrupt biomaterial logistics and hinder the development of cell therapy.